{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:33Z","timestamp":1791994593204,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Spanish Association Against Cancer Scientific Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"Caixabank SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010552","name":"Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"Commission of the European Communities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Gobierno de Espana Ministerio de Sanidad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xcrm.2026.102717","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:44:15Z","timestamp":1774968255000},"page":"102717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Elena","family":"Adan-Villaescusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Castello-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iker","family":"Uriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Barbero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Belzunce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"L\u00f3pez-Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ujue","family":"Latasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Elurbide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliana","family":"Valbuena-Goiricelaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agavni","family":"Mesropian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillem","family":"Cano-Segarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Hern\u00e1ndez de Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Nevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Vespasiani-Gentilucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pineda-Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sangro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josepmaria","family":"Argemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Sarobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gris-Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Pinyol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Llovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Arechederra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Berasain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Cocozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Gibaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias A.","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite G.","family":"Fernandez-Barrena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102717_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102717_bib2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41571-024-00868-0","article-title":"Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma","volume":"21","author":"Llovet","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17020236","article-title":"Next-Generation Immunotherapy for Hepatocellular Carcinoma: Mechanisms of Resistance and Novel Treatment Approaches","volume":"17","author":"Eghbali","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102717_bib6","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.2147\/JHC.S291553","article-title":"Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma","volume":"10","author":"Manfredi","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.xcrm.2026.102717_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.xcrm.2026.102717_bib8","article-title":"Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102717_bib9","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg","volume":"2","author":"Fern\u00e1ndez-Barrena","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.xcrm.2026.102717_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02297-2","article-title":"Epigenetic remodelling in human hepatocellular carcinoma","volume":"41","author":"Braghini","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/egastro-2025-100186","article-title":"Epigenetic mechanisms involved in hepatocellular carcinoma development and progression","volume":"3","author":"Bueloni","year":"2025","journal-title":"eGastroenterology"},{"key":"10.1016\/j.xcrm.2026.102717_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13105-025-01095-6","article-title":"Expression landscape of epigenetic genes in human hepatocellular carcinoma","volume":"81","author":"Castell\u00f3-Uribe","year":"2025","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.xcrm.2026.102717_bib13","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102717_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cellimm.2018.12.010","article-title":"Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma","volume":"336","author":"Hong","year":"2019","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.xcrm.2026.102717_bib15","article-title":"Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition","volume":"13","author":"Tao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102717_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30168","article-title":"Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma","volume":"69","author":"B\u00e1rcena-Varela","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102717_bib17","first-page":"118","article-title":"High Expression of G9a Induces Cisplatin Resistance in Hepatocellular Carcinoma","volume":"25","author":"Fu","year":"2023","journal-title":"Cell J."},{"key":"10.1016\/j.xcrm.2026.102717_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gutjnl-2019-320205","article-title":"Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis","volume":"70","author":"Barcena-Varela","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.102717_bib19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2023.05.031","article-title":"Identification and experimental validation of druggable epigenetic targets in hepatoblastoma","volume":"79","author":"Claver\u00eda-Cabello","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102717_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-024-03268-5","article-title":"Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma","volume":"44","author":"Oyon","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib21","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1158\/1535-7163.MCT-23-0613","article-title":"Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation","volume":"23","author":"Nguyen","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.xcrm.2026.102717_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","article-title":"Inflamed and non-inflamed classes of HCC: A revised immunogenomic classification","volume":"72","author":"Montironi","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2026.102717_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.gastro.2022.09.005","article-title":"Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma","volume":"164","author":"Haber","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102717_bib24","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102717_bib25","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1470-2045(23)00468-0","article-title":"Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab\u2013bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study","volume":"24","author":"Zeng","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43381-1","article-title":"PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma","volume":"14","author":"Cappuyns","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102717_bib27","article-title":"Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma","volume":"82","author":"Cappuyns","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102717_bib28","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","article-title":"Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma","volume":"73","author":"Sangro","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102717_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","article-title":"Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade","volume":"18","author":"Charoentong","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102717_bib30","doi-asserted-by":"crossref","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102717_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102717_bib32","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-11-2322","article-title":"Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib","volume":"18","author":"Lachenmayer","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib33","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"\u03b2-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102717_bib34","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1128\/MCB.00813-13","article-title":"Epigenetic regulation of autophagy by the methyltransferase G9a","volume":"33","author":"Artal-Martinez de Narvajas","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102717_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4161\/epi.23331","article-title":"G9a, a multipotent regulator of gene expression","volume":"8","author":"Shankar","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.xcrm.2026.102717_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2015.00487","article-title":"Functional Role of G9a Histone Methyltransferase in Cancer","volume":"6","author":"Casciello","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102717_bib37","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/1078-0432.CCR-20-3463","article-title":"G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma","volume":"27","author":"Kelly","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib38","article-title":"Identification and clinical implications of endogenous retrovirus elements suppressed by SETDB1 in hepatocellular carcinoma","volume":"7","author":"Igarashi","year":"2025","journal-title":"JHEP Rep."},{"key":"10.1016\/j.xcrm.2026.102717_bib39","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1158\/2159-8290.CD-21-0506","article-title":"Endogenous retroelements and the viral mimicry response in cancer therapy and cellular homeostasis","volume":"11","author":"Chen","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102717_bib40","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1158\/0008-5472.CAN-17-3953","article-title":"Dual inhibition of DNA and histone methyltransferases increases viral mimicry in ovarian cancer cells","volume":"78","author":"Liu","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib41","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.cell.2015.07.011","article-title":"Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses","volume":"162","author":"Chiappinelli","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102717_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-8935-6-15","article-title":"Distinct roles of KAP1, HP1 and G9a\/GLP in silencing of the two-cell-specific retrotransposon MERVL in mouse ES cells","volume":"6","author":"Maksakova","year":"2013","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.xcrm.2026.102717_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12032-023-02280-7","article-title":"Revolutionizing cancer treatment: comprehensive insights into immunotherapeutic strategies","volume":"41","author":"Raghani","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib44","article-title":"Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation","volume":"5","author":"Yoon","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2026.102717_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040865","article-title":"Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma","volume":"14","author":"Son","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2026.102717_bib46","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102717_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36160-5","article-title":"G9a\/GLP inhibition during ex vivo lymphocyte expansion increases in vivo cytotoxicity of engineered T cells against hepatocellular carcinoma","volume":"14","author":"Lam","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102717_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","article-title":"Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents","volume":"179","author":"Cao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.xcrm.2026.102717_bib50","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1165\/rcmb.2017-0286OC","article-title":"Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis","volume":"58","author":"Coward","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102717_bib51","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1016\/j.ymthe.2022.07.022","article-title":"BET inhibition triggers antitumor immunity by enhancing MHC class I expression in head and neck squamous cell carcinoma","volume":"30","author":"Zhang","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2026.102717_bib52","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/v12060596","article-title":"SETDB1-Mediated Silencing of Retroelements","volume":"12","author":"Fukuda","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2026.102717_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet J."},{"key":"10.1016\/j.xcrm.2026.102717_bib55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102717_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102717_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006701","article-title":"New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx","volume":"15","author":"Mounir","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.xcrm.2026.102717_bib58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102717_bib59","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/hep.27732","article-title":"DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma","volume":"61","author":"Villanueva","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102717_bib60","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1093\/bioinformatics\/btaa223","article-title":"corto: a lightweight R package for gene network inference and master regulator analysis","volume":"36","author":"Mercatelli","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102717_bib61","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa0804525","article-title":"Gene expression in fixed tissues and outcome in hepatocellular carcinoma","volume":"359","author":"Hoshida","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102717_bib62","series-title":"GenePattern 2.0 [2]","author":"Reich","year":"2006"},{"key":"10.1016\/j.xcrm.2026.102717_bib63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102717_bib64","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102717_bib65","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102717_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.102717_bib67","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.xcrm.2026.102717_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15424","article-title":"Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies","volume":"8","author":"San Jos\u00e9-En\u00e9riz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102717_bib70","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1093\/nar\/gkab649","article-title":"The splicing regulator SLU7 is required to preserve DNMT1 protein stability and DNA methylation","volume":"49","author":"Recalde","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.102717_bib71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/0023677215572000","article-title":"Partial hepatectomy in mice","volume":"49","author":"Nevzorova","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.xcrm.2026.102717_bib72","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12328-021-01394-7","article-title":"Intrahepatic recurrence of hepatocellular carcinoma after resection: an update","volume":"14","author":"Tampaki","year":"2021","journal-title":"Clin. J. Gastroenterol."},{"key":"10.1016\/j.xcrm.2026.102717_bib73","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2017.12.025","article-title":"Effects of the gut\u2013liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver","volume":"68","author":"Orci","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102717_bib74","doi-asserted-by":"crossref","first-page":"167166","DOI":"10.1016\/j.bbadis.2024.167166","article-title":"New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study","volume":"1870","author":"Uriarte","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126001345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:23:23Z","timestamp":1778919803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126001345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666379126001345"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102717","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102717","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102717"}}